Moderna says FDA will not consider its mRNA flu vaccine
Read Original Source
A sign marks an entrance to a Moderna building in Cambridge, Mass., May 18, 2020. (AP Photo/Bill Sikes, File) The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File) WASHINGTON (AP) — The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
AI Summary
Main Idea: The FDA will not review Moderna’s mRNA flu vaccine application, a setback for the company and a sign of tougher scrutiny on vaccines under Health Secretary Robert F. Kennedy Jr.
Key Points:
- Moderna said the FDA sent a “refusal-to-file” letter and would not accept the filing for review.
- The agency said the company’s trial did not compare the shot to the best available standard flu vaccine in the U.S.
- Moderna said the FDA had earlier allowed the study plan and that it also shared other trial data showing no safety or efficacy concerns.
- The decision comes as FDA leaders under Kennedy have taken a harder line on mRNA vaccines and other vaccine policies.
Impact on the People
Negative Impact
FDA delay could slow access to a new flu vaccine, leaving patients with fewer options and possibly less protection if a better shot is not approved.
Positive Impact
Greater FDA review may reduce the chance of a weak or poorly tested vaccine reaching consumers.
How did each entity affect people?
Rate how each entity in this article affected the American people.
No entity suggestions or linked entities saved yet.
Candidate Entities5 candidates · 5 weighted vote min · 70% decision
- Food and Drug Administrationgovernment agency or bodyPrimaryAI selected
Central regulator taking the key action of refusing to consider Moderna’s application.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Director Dr. Vinay PrasadpersonMajorAI selected
FDA vaccine director who authored the refusal-to-file letter and explained the agency’s decision.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Health Secretary Robert F. Kennedy Jr.personMajorAI selected
Named official whose scrutiny of vaccines and mRNA technology is a major driver of the story.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Howard Hughes Medical Institutenonprofit / NGOMentionCandidate
Mentioned only as a source of support for AP Health and Science Department.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Robert Wood Johnson Foundationnonprofit / NGOMentionCandidate
Mentioned only as a source of support for AP Health and Science Department.
Include 0 (0%)Ignore 0 (0%)5 to threshold
Comments 0
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment